quality assurance manager at Metaclipse Therapeutics Corporation - Atlanta, Georgia, US
Metaclipse Therapeutics is a clinical stage biotech company developing next-generation immunotherapies to treat cancer & vaccines to prevent infectious diseases using our proprietary biological adjuvants. Our personalized immunotherapy platform, Membrex™, has demonstrated promising preclinical data across multiple solid tumors with Phase 1 clinical trials for triple negative breast cancer (TNBC) and head and neck cancer (HNSCC) to begin in 2024. We are committed to continuous innovation using biological adjuvants for therapeutic and preventative vaccines.